Skip to main content

Advertisement

Log in

FragClust and TestClust, two informatics tools for chemical structure hierarchical clustering analysis applied to lipidomics. The example of Alzheimer's disease

  • Research Paper
  • Published:
Analytical and Bioanalytical Chemistry Aims and scope Submit manuscript

An Erratum to this article was published on 19 February 2016

Abstract

Lipidomic analysis is able to measure simultaneously thousands of compounds belonging to a few lipid classes. In each lipid class, compounds differ only by the acyl radical, ranging between C10:0 (capric acid) and C24:0 (lignoceric acid). Although some metabolites have a peculiar pathological role, more often compounds belonging to a single lipid class exert the same biological effect. Here, we present a lipidomics workflow that extracts the tandem mass spectrometry data from individual files and uses them to group compounds into structurally homogeneous clusters by chemical structure hierarchical clustering analysis (CHCA). The case-to-control peak area ratios of the metabolites are then analyzed within clusters. We created two freely available applications to assist the workflow: FragClust to generate the tables to be subjected to CHCA, and TestClust to perform statistical analysis on clustered data. We used the lipidomics data from the plasma of Alzheimer's disease (AD) patients in comparison with healthy controls to test the workflow. To date, the search for plasma biomarkers in AD has not provided reliable results. This article shows that the workflow is helpful to understand the behavior of whole lipid classes in plasma of AD patients.

Chemical Hierarchical Cluster Analysis applied to Lipidomics. Software assisted workflow.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Li M, Yang L, Bai Y, Liu H. Analytical methods in lipidomics and their applications. Anal Chem. 2014;86:61–75.

    Google Scholar 

  2. Hu C, van der Heijden R, Wang M, van der Greef J, Hankemeier T, Xu G. Analytical strategies in lipidomics and applications in disease biomarker discovery. J Chromatogr B. 2009;877:2836–46.

    Article  CAS  Google Scholar 

  3. Meikle PJ, Christopher MJ. Lipidomics is providing new insight into the metabolic syndrome and its sequelae. Curr Opin Lipidol. 2011;22:210–5.

    Article  CAS  Google Scholar 

  4. Rolim AE, Henrique-Araújo R, Ferraz EG, de AraújoAlvesDultra FK, Fernandez LG. Lipidomics in the study of lipid metabolism: current perspectives in the omic sciences. Gene. 2015;554(2):131–9.

    Article  CAS  Google Scholar 

  5. González-Domínguez R, García-Barrera T, Gómez-Ariza JL. Metabolomic study of lipids in serum for biomarker discovery in Alzheimer's disease using direct infusion mass spectrometry. J Pharm Biomed Anal. 2014;98:321–6.

    Article  Google Scholar 

  6. Mapstone M, Cheema AK, Fiandaca MS, Zhong X, Mhyre TR, MacArthur LH, et al. Plasma phospholipids identify antecedent memory impairment in older adults. Nat Med. 2014;20(4):415–8.

    Article  CAS  Google Scholar 

  7. Watson AD. Thematic review series: systems biology approaches to metabolic and cardiovascular disorders. Lipidomics: a global approach to lipid analysis in biological systems. J Lipid Res. 2006;47(10):2101–11.

    Article  CAS  Google Scholar 

  8. Summers SA. Ceramides in insulin resistance and lipotoxicity. Prog Lipid Res. 2006;45(1):42–72.

    Article  CAS  Google Scholar 

  9. Mathias S, Peña LA, Kolesnick RN. Signal transduction of stress via ceramide. Biochem J. 1998;335(3):465–80.

    Article  CAS  Google Scholar 

  10. Myers DS, Ivanova PT, Milne SB, Brown HA. Quantitative analysis of glycerophospholipids by LC-MS: acquisition, data handling, and interpretation. Biochim Biophys Acta. 2011;1811(11):748–57.

    Article  CAS  Google Scholar 

  11. Backman TW, Cao Y, Girke T. ChemMine tools: an online service for analyzing and clustering small molecules. Nucleic Acids Res. 2011;39 Suppl 2:W486–91.

    Article  CAS  Google Scholar 

  12. Camarda R, Monastero R. Prevalence of primary headaches in Italian elderly: preliminary data from the Zabút Aging Project. Neurol Sci Suppl. 2003;2:S122–4.

    Google Scholar 

  13. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington: American Psychiatric Association; 1994.

    Google Scholar 

  14. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDSADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984;34(7):939–44.

    Article  CAS  Google Scholar 

  15. Monastero R, Cefalù AB, Camarda C, Noto D, Camarda LK, Caldarella R, et al. Association of estrogen receptor alpha gene with Alzheimer's disease: a case–control study. J Alzheimers Dis. 2006;9(3):273–8.

    CAS  Google Scholar 

  16. Bird SS, Marur VR, Sniatynski MJ, Greenberg HK, Kristal BS. Serum lipidomics profiling using LC-MS and high-energy collisional dissociation fragmentation: focus on triglyceride detection and characterization. Anal Chem. 2011;83(17):6648–57.

    Article  CAS  Google Scholar 

  17. Zhang Y, Wen Z, Washburn MP, Florens L. Effect of dynamic exclusion duration on spectral count based quantitative proteomics. Anal Chem. 2009;81(15):6317–26.

    Article  CAS  Google Scholar 

  18. Hodge K, Have ST, Hutton L, Lamond AI. Cleaning up the masses: exclusion lists to reduce contamination with HPLC-MS/MS. J Proteomics. 2013;88:92–103.

    Article  CAS  Google Scholar 

  19. Smith CA, Want EJ, O'Maille G, Abagyan R, Siuzdak G. XCMS: processing mass spectrometry data for metabolite profiling using nonlinear peak alignment, matching and identification. Anal Chem. 2006;78:779–87.

    Article  CAS  Google Scholar 

  20. Kuhl C, Tautenhahn R, Böttcher C, Larson TR, Neumann S. CAMERA: an integrated strategy for compound spectra extraction and annotation of liquid chromatography/mass spectrometry data sets. Anal Chem. 2012;84(1):283–9.

    Article  CAS  Google Scholar 

  21. Smith CA, O'Maille G, Want EJ, Qin C, Trauger SA, Brandon TR, et al. METLIN: a metabolite mass spectral database. Ther Drug Monit. 2005;27(6):747–51.

    Article  CAS  Google Scholar 

  22. Fahy E, Subramaniam S, Brown HA, Glass CK, Merrill Jr AH, Murphy RC, et al. A comprehensive classification system for lipids. J Lipid Res. 2005;46(5):839–61.

    Article  CAS  Google Scholar 

  23. de Hoon MJ, Imoto S, Nolan J, Miyano S. Open source clustering software. Bioinformatics. 2004;20(9):1453–4.

    Article  Google Scholar 

  24. Saldanha AJ. Java Treeview—extensible visualization of microarray data. Bioinformatics. 2004;20(17):3246–8.

    Article  CAS  Google Scholar 

  25. Chen Y, Liu Y, Sullards MC, Merrill Jr AH. An introduction to sphingolipid metabolism and analysis by new technologies. Neuromol Med. 2010;2(4):306–19.

    Article  Google Scholar 

  26. Butovich IA. On the lipid composition of human meibum and tears: comparative analysis of nonpolar lipids. Investig Ophthalmol Vis Sci. 2008;49(9):3779–89.

    Article  Google Scholar 

  27. Tong H, Bell D, Tabei K, Siegel MM. Automated data massaging, interpretation, and E-mailing modules for high throughput open access mass spectrometry. J Am Soc Mass Spectrom. 1999;10:1174–8.

    Article  CAS  Google Scholar 

  28. Busik JV, Reid GE, Lydic TA. Global analysis of retina lipids by complementary precursor ion and neutral loss mode tandem mass spectrometry. Methods Mol Biol. 2009;579:33–70.

    Article  CAS  Google Scholar 

  29. Kemppinen A, Kalo P. Quantification of triacylglycerols in butterfat by gas chromatography-electron impact mass spectrometry using molar correction factors for [M-RCOO] + ions. J Chromatogr A. 2006;1134(1–2):260–83.

    Article  CAS  Google Scholar 

  30. Sun GY, Xu J, Jensen MD, Simonyi A. Phospholipase A2 in the central nervous system: implications for neurodegenerative diseases. J Lipid Res. 2004;45(2):205–13.

    Article  CAS  Google Scholar 

Download references

Acknowledgments

The authors thank Leopoldo Ceraulo from the University of Palermo for his precious contribution in the writing and proofreading of the manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Maurizio R. Averna.

Ethics declarations

The study was approved by the local ethics committee and written informed consent was obtained from all participants or their legal representatives. The procedures adopted were in accordance with the Helsinki Declaration of 1975, as revised in 1983, and were approved by the Ethics Committee of the University of Palermo.

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Francesca Di Gaudio, Sergio Indelicato contributed equally to this work.

Davide Noto and Maurizio R. Averna contributed equally to this work.

Electronic supplementary material

Below is the link to the electronic supplementary material.

ESM 1

(PDF 1079 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Di Gaudio, F., Indelicato, S., Monastero, R. et al. FragClust and TestClust, two informatics tools for chemical structure hierarchical clustering analysis applied to lipidomics. The example of Alzheimer's disease. Anal Bioanal Chem 408, 2215–2226 (2016). https://doi.org/10.1007/s00216-015-9229-6

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00216-015-9229-6

Keywords

Navigation